Remote Patient Monitoring Devices Market – By Product (Cardiac Monitoring Devices, Blood Pressure Monitoring Devices, Neurological Monitoring Devices), Application (Cardiovascular Diseases, Cancer, Diabetes), End-use – Global Forecast 2024 – 2032

Remote Patient Monitoring Devices Market Size

Remote Patient Monitoring Devices Market size was valued at around USD 15.8 billion in 2023 and is estimated to grow at 11.7% CAGR from 2024 to 2032. Remote patient monitoring (RPM) devices are advanced tools that enable the continuous, real-time tracking of patients' health outside traditional clinical settings.
 

These devices, ranging from wearable sensors to implantable and handheld instruments, monitor various physiological parameters such as heart rate, blood pressure, and glucose levels. The data is transmitted wirelessly to healthcare providers, allowing for real-time health assessments, improved patient engagement, reduced hospital readmissions, and support for value-based healthcare models.
 

The rising incidence of chronic diseases, such as diabetes, cardiovascular diseases, cancer, and chronic kidney disease (CKD), is a significant driver of market growth. For instance, according to a report from the World Heart Federation (WHF), global deaths from cardiovascular disease (CVD) surged to 20.5 million in 2021. CVD was the leading cause of death worldwide in 2021, with 80% of these deaths occurring in low- and middle-income countries (LMICs). This underscores the growing need for remote patient monitoring devices to enable early detection, continuous management, and timely intervention in managing cardiovascular conditions.
 

Additionally, growing disposable income and healthcare expenditure in emerging countries, along with technological advancements in developed nations, and the increasing adoption of remote patient monitoring devices, are key factors driving market growth.
 

Remote Patient Monitoring Devices Market Trends

Technological advancements in remote patient monitoring (RPM) devices have revolutionized healthcare in developed nations, enhancing both patient care and management. Innovations in IoT and artificial intelligence (AI) in healthcare, along with improvements in wearable technology, sensor accuracy, and telehealth integration, have led to more effective and personalized monitoring solutions.
 

• Modern RPM devices are increasingly integrated with the Internet of Things (IoT) and AI. These technologies enable real-time data collection, analysis, and automated decision-making. AI algorithms can predict potential health issues by analyzing data trends, improving early diagnosis and personalized care.
   
• Advances in wearable technology, such as smartwatches and fitness trackers, have enhanced RPM capabilities. These devices can continuously monitor vital signs such as heart rate, blood pressure, and glucose levels, providing valuable data for both patients and healthcare providers.
   
• Additionally, innovations in biosensor technology have led to more accurate and reliable monitoring devices. New sensors can track a wide range of physiological parameters with high precision, including blood oxygen levels, respiratory rates, and even sleep patterns, thus propelling the growth of the market.
   

Remote Patient Monitoring Devices Market Analysis

Based on product, the market is divided into cardiac monitoring devices, blood pressure monitoring devices, neurological monitoring devices, multiparameter monitoring devices, blood glucose monitoring devices, fetal and neonatal monitoring devices, sleep monitoring devices and other monitoring devices. The cardiac devices segment of the market is forecasted to reach USD 9.8 billion by 2032.
 

• Cardiac monitoring devices provide continuous, real-time tracking of heart rhythms, heart rate, and other vital cardiac metrics, allowing for the immediate detection of abnormal heart activities and prompt medical intervention if needed.
   
• By continuously monitoring heart activity, these devices can detect early signs of conditions such as arrhythmias, atrial fibrillation, and heart attacks. Early detection improves the chances of successful treatment and reduces the risk of severe complications.
   
• Additionally, modern cardiac monitoring devices utilize advanced sensors and algorithms to ensure high accuracy in capturing heart metrics. This precise data helps healthcare providers make more informed decisions and tailor treatments to individual needs, thereby escalating market growth.
   

Based on application, the remote patient monitoring devices market is bifurcated into cardiovascular diseases, cancer, diabetes, neurological disorders, infectious diseases, respiratory diseases, and other applications. The cardiovascular diseases segment accounted for USD 3 billion in 2023.
 

• Cardiovascular diseases (CVDs), such as hypertension, congestive heart failure, and arrhythmias, are among the leading causes of morbidity and mortality globally.
   
• For instance, according to the World Health Organization (WHO), CVDs accounted for approximately 17.9 million deaths annually in 2019, making them a significant public health concern.
   
• Cardiovascular diseases often require continuous monitoring of heart metrics, such as heart rate, blood pressure, and electrocardiograms (ECGs). RPM (Remote Patient Monitoring) devices provide real-time, continuous monitoring, allowing for early detection of abnormalities or exacerbations in the condition.
   
• Furthermore, RPM devices aid in the early detection of potential complications related to cardiovascular diseases, such as arrhythmias, heart attacks, or worsening heart failure. Early detection enables timely intervention, potentially preventing severe outcomes and hospitalizations, thereby driving market growth.
   

Based on end-use, the remote patient monitoring devices market is bifurcated into home-care settings, long-term care, and others. The home-care settings segment accounted for USD 8.3 billion in 2023.
 

• As healthcare systems worldwide emphasize patient-centered care and cost-effective solutions, RPM (Remote Patient Monitoring) devices have gained traction in home-care settings due to their ability to monitor patients' health remotely and continuously.
   
• By reducing the need for in-person visits and hospital admissions, RPM devices can lower healthcare costs for both patients and healthcare systems. This includes savings on transportation, hospital stays, and related expenses.
   
• Moreover, RPM devices provide continuous and detailed health data, which allows for the development of tailored care plans. Healthcare providers can adjust treatments and interventions based on real-time data, ensuring more personalized and effective care.
   

The growth of the remote patient monitoring devices market in the U.S., projected to reach USD 14.8 billion by 2032.
 

• The U.S. is a leader in technological innovation, supported by a robust infrastructure that facilitates the development and deployment of advanced RPM (Remote Patient Monitoring) devices. This infrastructure includes high-speed internet, sophisticated data centers, and cutting-edge technology platforms.
   
• The rising incidence of diabetes significantly contributes to the market's notable expansion. For example, according to the Public Health Agency of Canada, approximately 9.4% of the population, equivalent to 3.7 million individuals, were diagnosed with diabetes in 2021, with a prevalence of 10% in males and 8.7% in females. These factors are anticipated to further drive market growth.
   

The remote patient monitoring devices market in UK is expected to experience significant and promising growth from 2024 to 2032.
 

• The NHS, one of the world's largest publicly funded health services, actively integrates RPM devices into its care models. The NHS’s support for digital health initiatives and its commitment to improving patient care through technology drive the adoption of RPM devices.
   
• The UK is a hub for medical research and innovation, including studies on omega-3 fatty acids. Ongoing research and clinical trials contribute to the development of new omega-3 prescription drugs and enhance the understanding of their benefits
   

Japan remote patient monitoring devices market is anticipated to witness lucrative growth between 2024 – 2032.
 

• Japan has one of the highest proportions of elderly individuals in the world. This demographic trend increases the demand for RPM devices to monitor and manage chronic conditions and improve the quality of life for aging patients.
   
• Japan invests significantly in R&D across various sectors, including healthcare technology. This investment drives innovation in RPM devices, leading to advanced solutions with improved functionality and accuracy.
   

The remote patient monitoring devices market in Saudi Arabia is expected to experience significant and promising growth from 2024 to 2032.
 

• Saudi Arabia is actively expanding its telemedicine services, which complement the use of RPM devices. The integration of RPM with telemedicine platforms enables remote consultations and continuous monitoring, enhancing patient care.
   

Remote Patient Monitoring Devices Market Share

The remote patient monitoring devices industry is characterized by intense competition, with both major global companies and smaller to medium-sized firms vying for market dominance. A key component of market strategy is the consistent launch of innovative products utilizing various technologies. Major industry leaders play a significant role in driving innovation by making substantial investments in research and development. Moreover, strategic partnerships, acquisitions, and mergers are crucial for strengthening market positions and enhancing international presence.
 

Remote Patient Monitoring Devices Market Companies

Some of the eminent market participants operating in the remote patient monitoring devices industry include:

• Abbott Laboratories
• Cerner Corporation
• Baxter International Inc.
• Boston Scientific Corporation
• DexCom, Inc.
• F. Hoffmann-La Roche Ltd
• General Electric Company
• Johnson & Johnson
• Koninklijke Philips N.V
• Medtronic plc
• OMRON Corporation
• Siemens Healthineers AG    
• VitalConnect
   

Remote Patient Monitoring Devices Industry News:

• In August 2022, Medtronic plc formed a strategic partnership with BioIntelliSense for exclusive U.S. distribution rights of the BioButton wearable, enabling continuous, connected monitoring. This partnership enhanced Medtronic's remote monitoring capabilities and market presence.
   
• In November 2022, Boston Scientific Corporation launched the LUX-Dx Insertable Cardiac Monitor (ICM) System in Europe, a device for detecting arrhythmias. This expansion strengthened its cardiac monitoring portfolio and competitive position in the European market.
   

The remote patient monitoring devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Cardiac monitoring devices
• Blood pressure monitoring devices
• Neurological monitoring devices
• Respiratory monitoring devices
• Multiparameter monitoring devices
• Blood glucose monitoring devices
• Fetal and neonatal monitoring devices
• Sleep monitoring devices
• Other monitoring devices

Market, By Application

• Cardiovascular diseases
• Cancer
• Diabetes
• Neurological disorders
• Infectious diseases
• Respiratory diseases
• Other applications

Market, By End-use

• Home-care settings
• Long-term care
• Other end-users

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Poland
  • Switzerland
  • Netherlands
  • Rest of Europe 
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Thailand
  • Indonesia
  • Rest of Asia Pacific 
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
  • Rest of Latin America 
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Rest of Middle East and Africa